Skip to content
Rheumatology Letter
  • Blog
  • About Us
  • Annals of Rheumatic Diseases
  • Current Opinion in Rheumatology
  • European Review | Rheumatology
  • Google News
  • Helio.com
  • JCR
  • Medpage
  • Medscape
  • Nature Reviews Rheumatology
  • NEJM
  • News-Medical.net | Rheumatology
  • Newsletters
  • PubMed
  • Rheumatology
  • Rheumatology Network Articles
  • RheumNow
  • Scandinavian Journal of Rheumatology
  • Science Direct
  • The Journal of Rheumatology
  • The Lancet
  • The Rheumatologist
  • Wiley
  • Blog
  • About Us
  • Annals of Rheumatic Diseases
  • Current Opinion in Rheumatology
  • European Review | Rheumatology
  • Google News
  • Helio.com
  • JCR
  • Medpage
  • Medscape
  • Nature Reviews Rheumatology
  • NEJM
  • News-Medical.net | Rheumatology
  • Newsletters
  • PubMed
  • Rheumatology
  • Rheumatology Network Articles
  • RheumNow
  • Scandinavian Journal of Rheumatology
  • Science Direct
  • The Journal of Rheumatology
  • The Lancet
  • The Rheumatologist
  • Wiley
logo
Medpage

JAK Inhibitors’ Cancer Risk Confirmed in Real-World Data

  • by admin
  • June 27, 2025
(MedPage Today) — Use of Janus kinase (JAK) inhibitors for rheumatoid arthritis (RA) was associated with significantly… Read More
NEJM

Case 18-2025: A 63-Year-Old Woman with Dyspnea on Exertion

  • by admin
  • June 25, 2025
A 63-year-old woman was evaluated for dyspnea and edema. Soft-tissue thickening was noted in the retroperitoneum and… Read More
The Lancet

[Comment] The brain as a window into rheumatoid arthritis stratified medicine?

  • by admin
  • June 23, 2025
TNF inhibitors have transformed outcomes for many, but not all, people with rheumatoid arthritis. Their approval in… Read More
Rheumatology

Biomarkers in juvenile idiopathic arthritis: towards precision diagnosis and personalized therapy?

  • by admin
  • June 19, 2025
Purpose to review Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children, characterized… Read More
The Lancet

[Comment] Polymyalgia rheumatica: killing them softly

  • by admin
  • June 19, 2025
Polymyalgia rheumatica has long been neglected, especially when it comes to pharmaceutical development: but why? In 2025,… Read More
NEJM

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis

  • by admin
  • June 18, 2025
In adults with myasthenia gravis, treatment with intravenous inebilizumab, a CD19-specific monoclonal antibody, significantly improved function and… Read More
NEJM

Unruptured Intracranial Aneurysms

  • by admin
  • June 18, 2025
Intracranial aneurysms are common, and the risk of rupture is influenced by size, location, morphology, and factors… Read More
NEJM

Myasthenia Gravis — Redemption for B-Cell Depletion

  • by admin
  • June 18, 2025
Myasthenia gravis, an immune-mediated neurologic disorder, has for the past century been treated effectively with various immunotherapies,… Read More
NEJM

Progress through Persistence — Turning the Page in Pulmonary Fibrosis Clinical Trials

  • by admin
  • June 11, 2025
The field of pulmonary fibrosis has come a long way in the past 25 years, with the… Read More
NEJM

Case 16-2025: A 34-Year-Old Man with a Nasopharyngeal Mass

  • by admin
  • June 11, 2025
A 34-year-old man was admitted to the hospital because of left ear pain with hearing loss and… Read More
1 … 152 153 154 155 156 157

NewsBe Made by Couponvario | Powered by WordPress